Gladius Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19M | Buy |
77,700
+16,800
| +28% | +$3.91M | 0.85% | 28 |
|
|
2025
Q4 | $12.6M | Buy |
60,900
+31,700
| +109% | +$6.27M | 0.69% | 34 |
|
|
2025
Q3 | $5.41M | Buy |
29,200
+17,800
| +156% | +$3.05M | 0.57% | 43 |
|
|
2025
Q2 | $1.74M | Sell |
11,400
-12,700
| -53% | -$1.95M | 0.64% | 25 |
|
|
2025
Q1 | $4M | Sell |
24,100
-15,500
| -39% | -$2.43M | 1.06% | 25 |
|
|
2024
Q4 | $5.73M | Sell |
39,600
-2,100
| -5% | -$325K | 0.61% | 34 |
|
|
2024
Q3 | $6.76M | Buy |
41,700
+20,900
| +100% | +$3.33M | 0.81% | 24 |
|
|
2024
Q2 | $3.04M | Buy |
20,800
+6,200
| +42% | +$922K | 0.37% | 27 |
|
|
2024
Q1 | $2.31M | Sell |
14,600
-24,300
| -62% | -$3.87M | 0.76% | 24 |
|
|
2023
Q4 | $6.1M | Sell |
38,900
-19,700
| -34% | -$3.02M | 0.95% | 23 |
|
|
2023
Q3 | $9.13M | Buy |
58,600
+7,700
| +15% | +$1.27M | 0.38% | 54 |
|
|
2023
Q2 | $8.42M | Sell |
50,900
-34,700
| -41% | -$5.6M | 0.41% | 30 |
|
|
2023
Q1 | $13.3M | Buy |
85,600
+67,700
| +378% | +$10.9M | 0.77% | 30 |
|
|
2022
Q4 | $3.16M | Sell |
17,900
-20,400
| -53% | -$3.52M | 0.23% | 36 |
|
|
2022
Q3 | $6.26M | Buy |
38,300
+17,800
| +87% | +$3.01M | 0.28% | 42 |
|
|
2022
Q2 | $3.64M | Sell |
20,500
-8,400
| -29% | -$1.5M | 0.19% | 51 |
|
|
2022
Q1 | $5.12M | Sell |
28,900
-18,500
| -39% | -$3.15M | 0.38% | 33 |
|
|
2021
Q4 | $8.11M | Buy |
47,400
+25,800
| +119% | +$4.22M | 0.65% | 30 |
|
|
2021
Q3 | $3.49M | Hold |
21,600
| – | – | 0.25% | 24 |
|
|
2021
Q2 | $3.56M | Sell |
21,600
-203,200
| -90% | -$33.6M | 0.33% | 27 |
|
|
2021
Q1 | $36.9M | Buy |
224,800
+29,400
| +15% | +$4.76M | 1.39% | 16 |
|
|
2020
Q4 | $30.8M | Buy |
195,400
+164,600
| +534% | +$24.3M | 1.52% | 10 |
|
|
2020
Q3 | $4.59M | Buy |
+30,800
| New | +$4.56M | 0.46% | 29 |
|
|
2020
Q2 | – | Sell |
-42,800
| Closed | -$5.61M | – | 69 |
|
|
2020
Q1 | $5.61M | Sell |
42,800
-60,700
| -59% | -$8.61M | 0.59% | 15 |
|
|
2019
Q4 | $15.1M | Buy |
103,500
+22,200
| +27% | +$3.01M | 0.95% | 20 |
|
|
2019
Q3 | $10.5M | Buy |
81,300
+41,000
| +102% | +$5.4M | 0.48% | 40 |
|
|
2019
Q2 | $5.62M | Sell |
40,300
-114,300
| -74% | -$15.8M | 0.33% | 34 |
|
|
2019
Q1 | $21.6M | Buy |
154,600
+3,600
| +2% | +$482K | 1.19% | 12 |
|
|
2018
Q4 | $19.5M | Buy |
151,000
+130,900
| +651% | +$18.3M | 0.95% | 17 |
|
|
2018
Q3 | $2.78M | Sell |
20,100
-5,000
| -20% | -$664K | 0.27% | 13 |
|
|
2018
Q2 | $3.05K | Buy |
+25,100
| New | +$3.13M | 0.31% | 16 |
|
Other funds holding JNJ
VCM
VPM
Gladius Capital Management's JNJ Position: Q1 2026 in Review
Gladius Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,662 shares — an estimated $387K sold.
Gladius Capital Management first reported a position in JNJ in Q2 2018 and held it in 25 quarters. The position peaked at $11.8M in Q4 2018. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Gladius Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
- Gladius Capital Management sold 1,662 Johnson & Johnson shares in Q1 2026, an estimated $387K.
- Gladius Capital Management first reported a position in Johnson & Johnson in Q2 2018 and held it in 25 quarters.
- Gladius Capital Management's Johnson & Johnson position peaked at $11.8M in Q4 2018.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Gladius Capital Management's 13F filing for Q1 2026, filed 7 May 2026.